2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow VAP-cyclo protocol: new trials by email Literature Review of VAP-cyclo protocol trials Research Report on VAP-cyclo protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Go-CHOP as the Frontline Therapy for PTCL Golidocitinib, CHOP Regimen - Peripheral T Cell Lymphoma | Phase 2 | Unknown | Henan Cancer Hospital | 45 | 2023-08-03 | 2023-09-01 |
| Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides CHOP regimen, doxorubicin hydrochloride, etoposide - Lymphoma | Phase 2 | Unknown | National Cancer Institute (NCI) | 3 | 1993-06-01 | 2013-12-18 |
Lymphoma (1) · Lymphoma, T-Cell, Cutaneous (1) · Lymphoma, T-Cell, Peripheral (1)
Henan Cancer Hospital (1) · National Cancer Institute (NCI) (1)
China (1) · South Africa (1)
Keshu Zhou, Dr. (1) · Nicolas Novitzky, MD, PhD (1)